Shared Metabolic Profile of Caffeine in Parkinsonian Disorders

OBJECTIVE: The objective of this study was to determine comprehensive metabolic changes of caffeine in the serum of patients with parkinsonian disorders including Parkinson's disease (PD), progressive supranuclear palsy (PSP), and multiple system atrophy (MSA) and to compare this with healthy c...

Descripción completa

Detalles Bibliográficos
Autores principales: Takeshige‐Amano, Haruka, Saiki, Shinji, Fujimaki, Motoki, Ueno, Shin‐Ichi, Li, Yuanzhe, Hatano, Taku, Ishikawa, Kei‐Ichi, Oji, Yutaka, Mori, Akio, Okuzumi, Ayami, Tsunemi, Taiji, Daida, Kensuke, Ishiguro, Yuta, Imamichi, Yoko, Nanmo, Hisayoshi, Nojiri, Shuko, Funayama, Manabu, Hattori, Nobutaka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2020
Materias:
Regular Issue Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7496239/
https://www.ncbi.nlm.nih.gov/pubmed/32357260
http://dx.doi.org/10.1002/mds.28068

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7496239/
https://www.ncbi.nlm.nih.gov/pubmed/32357260
http://dx.doi.org/10.1002/mds.28068

Ejemplares similares